The Russian Health Ministry has registered the coronavirus medicine Mirobivir, created on the basis of a combination of nirmatrelvir and ritonavir.
"Mirobivir" was developed by the company "Pharmasintez". The medicine is registered on May 4 and available in the form of tablets with a dosage of 150 plus 100 mg.
According to the instructions for "Mirobivir", the medicine is indicated for the treatment of a new coronavirus infection of a mild or moderate course in adults, including an increased risk of progression of the disease to a severe course, which does not require additional oxygen therapy.
![November 2025 in photos: New Year at GUM, the "City of Living Stories," and autumn scenes](https://en.vestikavkaza.ru/upload2/s400xfull/2025-12-02/1764706769692f49d1538777.83780174.webp "November 2025 in photos: New Year at GUM, the "City of Living Stories," and autumn scenes")
!["City of Living Stories" Museum commemorating 1941 Parade starts on Red Square](https://en.vestikavkaza.ru/upload2/s400xfull/2025-11-11/1762891681691397a1526b44.05389807.webp ""City of Living Stories" Museum commemorating 1941 Parade starts on Red Square")
